Skip to Main Content

Paper Details

Long-term Overall Survival and Predictors in Anti-PD-1-naive Melanoma Patients With Brain Metastases Treated With Immune Checkpoint Inhibitors in the Real-world Setting: A Multicohort Study.
J Immunother
4
2021
Author NameAffiliation
Alistair E W JohnsonInstitute of Medical Engineering & Science, Massachusetts Institute of Technology
  • 1 - 1

Datasets

Release 1.2